These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31629443)

  • 61. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinoma.
    Raza SJ; Miller C; May A; Davaro F; Siddiqui SA; Hamilton Z
    Can J Urol; 2019 Aug; 26(4):9852-9858. PubMed ID: 31469641
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Impact of Hospital Volume on Short-term and Long-term Outcomes for Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Sui W; Wallis CJD; Luckenbaugh AN; Barocas DA; Chang SS; Penson DF; Resnick MJ; Laviana AA
    Urology; 2021 Jan; 147():135-142. PubMed ID: 32891638
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
    Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder.
    Rahman SN; Lokeshwar SD; Syed JS; Javier-Desloges JF; Press BH; Choksi AU; Rajwa P; Pradere B; Ploussard G; Kim JW; Monaghan TF; Renzulli JR; Shariat SF; Leapman MS
    Urol Oncol; 2023 Feb; 41(2):107.e1-107.e8. PubMed ID: 36481253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study.
    Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G
    J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of perioperative chemotherapy for upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
    Pinar U; Calleris G; Grobet-Jeandin E; Grande P; Benamran D; Thibault C; Gontero P; Rouprêt M; Seisen T
    World J Urol; 2023 Nov; 41(11):3205-3230. PubMed ID: 36905443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database.
    Celtik K; Lim K; Dursun F; Xu J; Klaassen Z; Zhang J; Efstathiou E; Sonpavde G; Wallis C; Satkunasivam R
    Clin Genitourin Cancer; 2022 Jun; 20(3):244-251. PubMed ID: 35181268
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
    J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
    Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.
    Liu Z; Huang J; Li X; Huang C; Ye Y; Zhang J; Liu Z
    Cancer Med; 2020 Aug; 9(16):5756-5766. PubMed ID: 32585775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract.
    Zareba P; Rosenzweig B; Winer AG; Coleman JA
    Cancer; 2017 May; 123(10):1741-1750. PubMed ID: 28152158
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
    Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
    Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
    Lerner SE; Blute ML; Richardson RL; Zincke H
    Mayo Clin Proc; 1996 Oct; 71(10):945-50. PubMed ID: 8820768
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma.
    Duplisea JJ; Petros FG; Li R; Fellman B; Guo CC; Czerniak BA; Siefker-Radtke AO; Araujo JC; Dinney CPN; Matin SF
    Urol Oncol; 2019 Jun; 37(6):354.e19-354.e26. PubMed ID: 30777393
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.
    Kim M; Kim JK; Lee J; Kim YS; Lee JL; Kwak C; Jeong CW; Byun SS; Lee SC; Ohyama C; Arai Y; Ahn H
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):819-827. PubMed ID: 30922943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.